MARLANA KEETON: Open Payments
NPI 1023551504 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 82 payments from 17 companies in 2025. Trend: 2023 $2,885 · 2024 $2,270 · 2025 $1,740
Food & beverage: $1,650Education: $90
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 29 | $378 |
| AstraZeneca Pharmaceuticals LP | 10 | $318 |
| Insmed, Inc. | 7 | $193 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $139 |
| JAZZ PHARMACEUTICALS INC. | 2 | $125 |
| Viatris Specialty LLC | 4 | $76 |
| HARMONY BIOSCIENCES LLC | 3 | $73 |
| GENZYME CORPORATION | 2 | $68 |
| Grifols USA, LLC | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $65 |
Products named: NUCALA, TEZSPIRE, Arikayce, XYWAV, DUPIXENT, TRELEGY ELLIPTA, YUPELRI, WAKIX.
Industry payments across KY — which companies pay providers there.
